TY - JOUR
T1 - Worldwide Index of Serotype-Specific Pneumococcal Antibody Responses (WISSPAR)
T2 - A curated database of clinical trial data
AU - Perniciaro, Stephanie
AU - Cooper-Wooton, Dominic
AU - Knoll, Maria
AU - Weinberger, Daniel
N1 - Funding Information:
This work was supported by the Bill and Melinda Gates Foundation [INV-007834].
Funding Information:
Competing interests: DMW has received consulting fees from Pfizer, Merck, Affinivax, Matrivax, and GSK for work unrelated to this manuscript and is principal investigator on grants from Pfizer and Merck to Yale University for work unrelated to this manuscript. SP has received consulting fees from Global Diagnostic Solutions, Inventprise, and Vaxcyte and is principal investigator on a grant from Merck to Yale University. MDK has received consulting fees from Merck for work unrelated to this manuscript and receives funding from Pfizer and Merck contracts with the Johns Hopkins University for work unrelated to this manuscript. DC-W has no competing interests to disclose.
Publisher Copyright:
Copyright: © 2023 Perniciaro S et al.
PY - 2023
Y1 - 2023
N2 - The Worldwide Index of Serotype Specific Pneumococcal Antibody Responses (WISSPAR; https://wisspar.com), is a centralized, online platform housing data on immunogenicity from clinical trials of pneumococcal vaccines. The data on WISSPAR are primarily curated from outcomes tables from clinical trials and are made available in a searchable format that can be readily used for downstream analyses. The WISSPAR database includes trials covering numerous vaccine products, manufacturers, dosing schedules, age groups, immunocompromised groups, and geographic regions. Customizable data visualization tools are embedded within the site, or the data can be exported for further analyses. Users can also browse summary information about the clinical trials and their results. WISSPAR provides a platform for analysts and policy makers to efficiently gather, compare, and collate clinical trial data about pneumococcal vaccines.
AB - The Worldwide Index of Serotype Specific Pneumococcal Antibody Responses (WISSPAR; https://wisspar.com), is a centralized, online platform housing data on immunogenicity from clinical trials of pneumococcal vaccines. The data on WISSPAR are primarily curated from outcomes tables from clinical trials and are made available in a searchable format that can be readily used for downstream analyses. The WISSPAR database includes trials covering numerous vaccine products, manufacturers, dosing schedules, age groups, immunocompromised groups, and geographic regions. Customizable data visualization tools are embedded within the site, or the data can be exported for further analyses. Users can also browse summary information about the clinical trials and their results. WISSPAR provides a platform for analysts and policy makers to efficiently gather, compare, and collate clinical trial data about pneumococcal vaccines.
KW - clinical trials
KW - immunogenicity
KW - pneumococcal conjugate vaccines
KW - pneumococcal disease
KW - Streptococcus pneumoniae
UR - http://www.scopus.com/inward/record.url?scp=85168807453&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85168807453&partnerID=8YFLogxK
U2 - 10.12688/gatesopenres.14768.1
DO - 10.12688/gatesopenres.14768.1
M3 - Article
C2 - 37564746
AN - SCOPUS:85168807453
SN - 2572-4754
VL - 7
JO - Gates Open Research
JF - Gates Open Research
M1 - 109
ER -